1. Scrip

Global Mechanism Needed To Monitor And Boost Use Of Influenza Vaccines, Particularly In Asia - Study

 
• By Alfred Romann

Although there is a visible uptrend in seasonal influenza vaccination, few countries reach recommended targets, IFPMA study finds.

HONG KONG – The world’s ability to produce influenza vaccines has risen sharply in recent years but few countries have stepped up vaccination campaigns against seasonal influenza, with most countries failing to meet even the “moderate” levels recommended by the World Health Organization.

A recent study published in the Elsevier journal Vaccine suggests countries could do a better job in terms of communication with the public and in reimbursements to expand vaccination coverage....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

Merus Bispecific Impresses In Head And Neck Cancer

 
• By Andrew McConaghie

Updated Phase II results from petosemtamab have impressed ahead of ASCO, outshining Keytruda monotherapy and its bispecific rival from Bicara.

Zydus To Continue Mirabegron Sales, Looks To World-First Dual Shigella-Typhoid Vaccine

 
• By Vibha Ravi

Zydus expects strong mirabegron sales in FY26 amid US litigation even as it builds a growth pillar in vaccines with a world-first, Gates Foundation-aided dual shigella-typhoid vaccine under development and others on the WHO prequalified list

Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma

 
• By Jessica Merrill

The royalty revenue stream acquirer has around 40 products in its portfolio and expects to generate roughly $3bn this year. Head of R&D and investments Marshall Urist talked about the investment strategy at the RBC Healthcare Conference.